#nucleic acid sample preparation kits market
Text
Nucleic Acid Sample Preparation Kits Market Future Trends to Look Out | Bis Research
Nucleic acid sample preparation kits are specialized sets of reagents and protocols designed to extract, purify, and amplify nucleic acids (such as DNA or RNA) from biological samples.
The global nucleic acid sample preparation market is projected to reach $5,615.9 million by 2033 from $2,922.8 million in 2023, growing at a CAGR of 6.75% during the forecast period 2023-2033.
Nucleic Acid Sample Preparation Kits Overview
These kits typically include various components such as buffers, enzymes, columns, and beads optimized for specific sample types (e.g., blood, tissue, or microbial cultures) and downstream applications (e.g., PCR, sequencing, or cloning).
The process of nucleic acid sample preparation involves lysing cells or disrupting tissues to release nucleic acids, removing contaminants (e.g., proteins, lipids, and inhibitors), and concentrating or amplifying the nucleic acids for subsequent analysis.
Nucleic acid sample preparation kits play a crucial role in molecular biology and diagnostic workflows, enabling researchers and clinicians to obtain high-quality nucleic acid samples for a wide range of applications, including research, clinical diagnostics, forensics, and personalized medicine.
Grab a look at the free sample page for more understanding click here !
Key Market Players
Agilent Technologies, Inc.
Autogen, Inc.
Bio-Rad Laboratories, Inc.
Roche AG
Merck KGaA
and many others
The Nucleic Acid Isolation and Purification Market has made an impact in the following ways:
Visit our Precision Medicine Vertical Page Click Here !
Market Segmentation
Product Type
End Users
Applications
Geography
Various different applications involved are as follows
Drug development and discovery
Agriculture Biotechnology
Molecular Diagnosis
Market Dynamics for Nucleic Acid Sample Preparation
Market Drivers
increasing prevalence of market disease and cancer cases
growing number of genetic tests
Market Restraints
genomic data protection
Market Opportunities
Development and utilization of biobanks in healthcare sector
Recent Developments in the Nucleic Acid Sample Preparation Market
Qiagen N.V. introduced two groundbreaking additions to its sample technologies portfolio, i.e., the TissueLyser III that facilitates high-throughput disruption of diverse biological samples and the RNeasy PowerMax Soil Pro Kit that isolates high-purity RNA from challenging soil samples using advanced Inhibitor Removal Technology.
PerkinElmer introduced the CHEF Magnetic Bead Cleanup System, providing automated nucleic acid purification through advanced magnetic bead technology. This novel system would help automate the nucleic acid purification process efficiently.
Conclusion
In conclusion, nucleic acid sample preparation kits play a fundamental role in modern molecular biology and diagnostics, offering a versatile and efficient solution for extracting, purifying, and amplifying nucleic acids from various biological samples.
With ongoing advancements in technology and innovation, nucleic acid sample preparation kits continue to evolve, driving progress in diverse fields and contributing to improvements in human health, environmental sustainability, and global well-being.
0 notes
Text
Desalting and Buffer Exchange Market Size, Industry Trends and Forecast to 2028
This Desalting and Buffer Exchange market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and supply chain dynamics, and insights about new geographical markets. The market insights covered in Desalting and Buffer Exchange report simplifies managing marketing of goods and services effectively.
The desalting and buffer exchange market is expected to significantly gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to increase at a CAGR of 15.25% in the above-mentioned forecast period.
Download Sample PDF Copy of this Report to understand structure of the complete report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-desalting-and-buffer-exchange-market
Market Overview:
Desalting is a method of detaching from protein and nucleic acid samples for soluble low molecular weight substances. The replacement of one set of buffer salts with another set is buffer exchange. With the help of gel filtration chromatography which is also referred to as size exclusive chromatography, these two processes can be carried out. During the desalination process, chromatographic columns are balanced with water, while the columns are balanced in buffer exchange with buffer salts so either various buffer salts or water replace the salt-containing solution. A solution containing macromolecules is passed through a column packed with resin in the process of gel filtration. Large macromolecules enter the resin pores and pass through the column swiftly. In contrast, when entering the resin pores, smaller macromolecules and buffer salt slow their migration rate through the resin bed. Additionally, during the preparation of biological samples, buffer exchange is an especially important step, as it prepares the sample for downstream implementations.
Some of the major players operating in the Desalting and Buffer Exchange market are Thermo Fisher Scientific, Inc., Avantor Inc., Bio-Rad Laboratories Inc., Merck KGaA, Danaher, General Electric Company, REPLIGEN CORPORATION, Sartorius, Agilent Technologies Inc., PhyNexus Inc., Biotage, Norgen Biotek Corp. and Bio-Works Sweden AB among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. among others.
Global Desalting and Buffer Exchange Market Scope
The desalting and buffer exchange market is segmented on the basis of technique, product and application. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Based on technique, the desalting and buffer exchange market is segmented into filtration, chromatography and precipitation. Filtration is further segmented into ultrafiltration and dialysis. Chromatography is further segmented into size-exclusion chromatography and other chromatography techniques.
Based on product, the desalting and buffer exchange market is segmented into kit, cassettes & cartridges, filter plates, spin columns, membrane filters and other consumables and accessories.
Based on application, the desalting and buffer exchange market is segmented into bioprocess applications, pharmaceutical and biotechnology companies, CMOS & CROS, academic & research institutes and diagnostic applications.
Browse More About This Research Report @ https://www.databridgemarketresearch.com/reports/global-desalting-and-buffer-exchange-market
Table of Content:
Part 01: Executive Summary
Part 02: Scope of the Report
Part 03: Global Desalting and Buffer Exchange Market Landscape
Part 04: Global Desalting and Buffer Exchange Market Sizing
Part 05: Global Desalting and Buffer Exchange Market Segmentation By Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
Browse Trending Reports:
Global Burner Management System Market – Industry Trends and Forecast to 2028 https://www.databridgemarketresearch.com/reports/global-burner-management-system-market
Global Healthcare Enterprise Software Market – Industry Trends and Forecast to 2029 https://www.databridgemarketresearch.com/reports/global-healthcare-enterprise-software-market
Global Bacterial Vaccines Market – Industry Trends and Forecast to 2029 https://www.databridgemarketresearch.com/reports/global-bacterial-vaccines-market
Global Motion Control Software in Robotics Market – Industry Trends and Forecast to 2030 https://www.databridgemarketresearch.com/reports/global-motion-control-software-in-robotics-market
About Data Bridge Market Research:
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
Contact Us: -
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC: +653 1251 975
Email: – [email protected]
#Desalting and Buffer Exchange Market#Desalting and Buffer Exchange Market Growth#Desalting and Buffer Exchange Market Demand
0 notes
Text
DNA RNA Extraction Kit Market Size, Type, segmentation, growth and forecast 2023-2030
DNA RNA Extraction Kit Market
The DNA RNA Extraction Kit Market is expected to grow from USD 1.30 Billion in 2022 to USD 2.20 Billion by 2030, at a CAGR of 7.26% during the forecast period.
DNA RNA Extraction Kit Market Size
The DNA RNA Extraction Kit market research report analyzes the global market segment based on product type (DNA Extraction Kit, RNA Extraction Kit), end-use application (Hospital, Laboratory, Other), and geography (North America, Asia Pacific, Middle East, Africa, Australia and Europe), with the leading market players including Qiagen, Thermo Fisher Scientific, Merck KGaA, Roche, Cytiva, Agilent, Danaher, Promega, Bio-Rad, Bioneer, and Akonni Biosystems. The report dives deep into the dynamics of the market and the regulatory and legal factors, such as the increasing incidence of genetic disorders and the growing demand for personalized medicine and research on gene-based therapies. The market growth can be attributed to technological advancements, increasing research and development activities, and the need for quick, accurate, and efficient extraction of nucleic acids. The report anticipates continued market growth in the future.
DNA RNA Extraction Kit Market Key Player
Qiagen
Thermo Fisher Scientific
Merck KGaA
Roche
Cytiva
Buy Now & Get Exclusive Discount on this https://www.reportprime.com/enquiry/request-discount/11096
DNA RNA Extraction Kit Market Segment Analysis
The DNA RNA Extraction Kit market targets customers in research and biotechnology laboratories, pharmaceutical companies, academic institutions, and diagnostic centers. The increasing demand for effective and efficient research tools for genetic analysis and clinical diagnostics is driving the revenue growth of the DNA RNA Extraction Kit market. The rising incidence of genetic diseases, cancer, and infectious diseases have led to increased demand for DNA RNA Extraction Kits as a primary step in genetic analysis and diagnosis.
One of the latest trends in the DNA RNA Extraction Kit market is the development of fully automated and high-throughput extraction systems, which enable faster and more efficient extraction of DNA and RNA from different sample types. Moreover, the growing popularity of personalized medicine and genomic-based research is expected to fuel the demand for DNA RNA Extraction Kits in the coming years.
The major challenge faced by the DNA RNA Extraction Kit market is the high cost of these kits, which may limit their accessibility, particularly in developing countries. Additionally, quality control issues in sample preparation and the lack of standardization in DNA RNA extraction protocols may also restrain the growth of the market.
The main findings of the DNA RNA Extraction Kit market report suggest that North America holds the largest share due to the presence of major market players in the region, while the Asia-Pacific region is expected to witness the fastest growth due to the rising demand for molecular diagnostics in the region.
The report recommends market players to focus on product innovation, developing cost-effective and easy-to-use DNA RNA Extraction Kits, and expanding their global reach through strategic partnerships and collaborations. Additionally, the report suggests that regulatory bodies should establish standardized protocols for DNA RNA extraction to ensure consistency and reliability in research and clinical diagnostics.
This report covers impact on COVID-19 and Russia-Ukraine wars in detail.
Purchase This Report: https://www.reportprime.com/checkout?id=11096&price=3590
Market Segmentation (by Application):
Hospital
Laboratory
Other
Information is sourced from www.reportprime.com
0 notes
Text
Blood Screening Market Size (2022-2030) Industry Trends, Growth, Challenges, and Forecast: Growth Plus Reports
The global blood screening market is expected to develop considerably during the forecast period. The growth can be due to various factors such as higher blood donation rates, the prevalence of chronic illnesses and infectious diseases, and expanding economies. Other market drivers include the rapid development of new technologies and the introduction of enhanced products. Another beneficial factor in the market is the increase in healthcare initiatives or investments from public and private organizations.
The blood screening market was valued at US$ 2.3 billion in 2021. The market is expected to witness a CAGR of 8.1% from 2022 to 2030.
Growing chronic illness/disease occurrences also contribute to market expansion. An increase in such incidences is a prime cause of the rise in fatalities. The risk factors include poor eating habits, physical inactivity, and use of cigarettes/tobacco and alcohol. According to the WHO (World Health Organization) report for 2021, nearly 17.9 million people die every year due to chronic diseases such as cancers (9.3 million), respiratory diseases (4.1 million), and diabetes (1.5 million). Thus, these factors encourage the growth of the market globally.
Download Sample PDF Brochure: https://growthplusreports.com/inquiry/request-sample/blood-screening-market/7907
Key players:
· Ortho-Clinical Diagnostics Inc.
· Thermo Fisher Scientific Inc.
· Abbott Laboratories
· F. Hoffmann-La Roche AG
· Grifols S.A.
· Quotient Technology Inc.
· Bio-Rad Laboratories Inc.
· Becton, Dickinson and Company
· Danaher Corporation (Beckman Coulter)
· Siemens Healthineers
By Technology:
· ELISA
· Western Blot
· RT-PCR
· Rapid Test
· Nucleic Acid Amplification
By Product:
· Software
· Instrument
· Reagent & Kits
Regional Analysis-
· The Asia-Pacific market is anticipated to grow at a higher CAGR during the forecast period.
· Major factors contributing to the growth of Blood Screening market in this region include the rising incidence of chronic infectious diseases, rising awareness regarding growing applications of Blood Screening, and increasing research activities in the field of Blood Screening.
· The emergence of local players and new product launches has also played a critical role in boosting the Blood Screening market in this region.
Key Questions Answered in the Report Include:
(1) This report gives all the information about the industry analysis, revenue, and overview, of this market.
(2) What will be the rate of increase in market size and growth rate by the end of the forecast period?
(3) What are the major global Blood Screening Market trends influencing the development of the market?
(4) What are the vital results of SWOT analysis of the major players operating in the Blood Screening Market?
(5) What are the potential growth opportunities and threats faced by Major competitors in the market?
Browse the full report now: https://growthplusreports.com/report/blood-screening-market/7907
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
0 notes
Text
In-vitro Diagnostics (IVD) Reagents Market Worth $77.6 billion by 2027, Growing at a CAGR of 7% From 2020, Says Meticulous Research®
According to a new market research report “In-Vitro Diagnostic Reagents Market by Type (Oligonucleotide, Antibodies, Nucleic Acid Probe), Technology (Immunoassay, Hematology, Microbiology), Use (Research, Analyte Specific Reagent), End User (IVD Manufacturer, Clinical Laboratory) – Forecast to 2027”, published by Meticulous Research®, the IVD reagents market is expected to grow at a CAGR of 7% from 2020 to reach USD 77.6 billion by 2027.
Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5110
The epidemiological burden of infectious diseases across the globe has increased in the past few years. During past few decades, various infections such as Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), Ebola, chikungunya, avian flu, swine flu, and Zika are the majorly occurred emerging infections. The recent outbreak of the coronavirus (COVID-19) disease is an example of the same. Testing is one of the greatest tools in understanding and managing the pandemics. Apart from this, the advances in protein-engineering technologies, such as mass spectrometry; advances in molecular genetics; and progress in production technologies are some of the key drivers of the IVD reagents market. This has urged drug developers to exploit the functional characteristics of desired proteins by maintaining or enhancing product safety or efficacy. The fastest-growing class of therapeutic proteins is an antibody that includes bispecific mAbs and multispecific fusion proteins, and mAbs conjugated with small molecule drugs designed for the treatment of cancers, immune disorders, infections, and other diseases. According to a research article published in F1000Research (an innovative open access publishing platform), the recent developments in protein purification technologies and expression systems have increased the production of therapeutic peptides while maintaining product safety or efficacy or both at the same time. Due to this, the number of therapeutic peptides approvals has grown significantly over the past few years.
Further, government initiatives for the development of personalized medicines, which include monoclonal antibodies as its major part, boosted the production of antibodies. Therefore, the increasing demand for therapeutic proteins and personalized medicine and their subsequent increase in approvals is expected to create significant opportunities for the players operating in the IVD reagents market.
Impact of COVID-19 on the IVD Reagents Market
The COVID-19 pandemic has adversely hit many economies around the globe. In this global pandemic, although many dedicated healthcare professionals work tirelessly on the frontlines to fight against this crisis, it is equally important to minimize the spread of disease by preparing kits for early diagnosis. Thus, the outbreak of the COVID-19 pandemic has created immense opportunities for the IVD reagents market as testing has provided one of the greatest solutions in managing the pandemic. In response to the pandemic and shortages of laboratory-based molecular testing capacity and reagents, multiple diagnostic test manufacturers have developed and begun selling various assays & kits which are prepared by using the IVD reagents.
Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5110
Thus, this increase in the launch of newer diagnostic kits will result in the increased adoption of IVD reagents for the kits or the assay development, thereby providing lucrative opportunities for the IVD reagents manufactures in the upcoming years.
The overall IVD reagents market is mainly segmented by type (oligonucleotide, antibodies, nucleic acid probe), technology (immunoassay, hematology, microbiology), use (research, analyte specific reagent), end user (IVD manufacturer, clinical laboratory), and geography. The study also evaluates industry competitors and analyzes their market share at a global and regional level.
On the basis of technology, the immunoassay/immunochemistry segment accounted for the largest share of the overall IVD reagents market in 2020. However, the molecular diagnostics segment is expected to grow at the fastest CAGR during the forecast period due to factors such as the high prevalence of infectious diseases, rising awareness of personalized medicine and companion diagnostics, and advancements in molecular techniques. Further, the rising focus of market players on the development of diagnostic NGS kits and reagents and rising penetration of cutting-edge clinical laboratory technologies are also responsible for the fastest growth of the segment.
Base on the type of reagent, the antibodies segment accounted for the largest share of the overall market in 2020, owing to the widespread application of antibodies in medicine for the purpose of research, diagnosis, drug & IVD development, and disease treatment; increasing proteomics & genomics-based research and funding for R&D; and rising need for disease specific biomarkers.
On the basis of use of the IVD reagent, the clinical use segment commanded the largest share of the overall IVD reagent market in 2020. Rising number of initiatives undertaken by manufacturers for the development of advanced IVD reagents for clinical applications, ongoing clinical trials, and exemption from the investigational device (IDE) requirements are some of the factors driving the growth of this segment.
Based on the end user, reference laboratories accounted for the largest share of the overall IVD reagents market in 2020, due to factors such as the exponential increase in the number of accredited clinical laboratories, growing R&D activities in labs, presence of skilled professionals & well-equipped systems, and outbreak of COVID-19.
Quick Buy – IVD Reagent Market Research Report: https://www.meticulousresearch.com/Checkout/29579204
The report also includes extensive assessment of the product portfolio, geographic analysis, and key strategic developments adopted by leading market participants in the industry over the past 3 years. The IVD reagents market has witnessed number of collaborations and expansions in recent years.
Geographically, emerging economies like Asia-Pacific and Latin America are expected to offer significant growth opportunities for IVD reagents manufactures due to the rising demand for antibodies & oligonucleotides, increasing funding for R&D, rising healthcare expenditure, and ongoing developments in the healthcare infrastructure. Countries such as China, India, Brazil, and Mexico have been significant contributors to revenue generation for various stakeholders in the overall IVD reagents market. This is mainly due to the increasing number of research institutes, clinical & diagnostic laboratories, and pharmaceutical & biopharmaceutical industries. In addition, rising public & private funding for R&D and rising contract research in these countries are further supporting the growth of the IVD reagents market in these countries.
Some of the key players operating in the overall IVD reagents market are Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), LGC Biosearch Technologies (U.K.), BioLegend, Inc. (U.S.), InBios International, Inc. (U.S.), LakePharma, Inc. (U.S.), Bioline (U.K.), Abcam plc (U.K.), The Binding Site Group Ltd.(U.K.), SDIX, LLC (U.S.), DIACLONE SAS (France), Bio-Techne Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Hologic Inc. (U.S.), Bio-Synthesis Inc. (U.S.), RayBiotech, Inc. (U.S.), and Sino Biological Inc. (China), among others.
Scope of the Report:
IVD Reagents Market, by Technology
Immunoassay/Immunochemistry
Biochemistry/Clinical Chemistry
Molecular Diagnostics
Microbiology
Hematology
Coagulation/Hemostatis
Other technologies
Other Technologies comprises of hybridization and loop-mediated isothermal amplification
IVD Reagents Market, by Type
Antibodies
Oligonucleotides
Nucleic Acid Probes
Purified Proteins or Peptides
Other reagents
Other reagents comprises of blocking agents, detergents, surfactants, wetting agents, buffers, stabilizers, purified water, dyes, standards & controls, enzymes, cell culture reagents, anti-coagulants
IVD Reagents Market, by Use
Research Use
Analyte Specific Reagents
Clinical Use
IVD Reagents Market, by End User
IVD Manufacturers
Reference Laboratories
Academic & Research Institutes
Hospital Laboratories
IVD Reagents Market, by Geography
North America
U.S.
Canada
Europe
Germany
France
Italy
U.K.
Spain
Rest of Europe
Asia-Pacific (APAC)
Japan
China
India
Rest of Asia Pacific
Latin America
Middle East & Africa
Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5110
0 notes
Text
Blood Screening Market is anticipated to expand at a compound annual growth rate (CAGR) 6.9% from 2021 to 2031 | Grifols (Spain), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories, Inc. (US)
The blood screening market size was USD 2.8 billion in 2021 and it is anticipated to reach USD 5.5 billion in 2031, growing at a CAGR of 6.9% from 2022-2031.
Global Blood Screening Market report from Global Insight Services is the single authoritative source of intelligence on Blood Screening Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Blood screening is a medical process in which blood is examined for a specific disease or condition. It aids in monitoring disease and preventing health issue and a variety of other conditions such as infection and cancer. Human Immunodeficiency Virus (HIV), blood type, and pregnancy screenings are the most common types of blood screening.
Get Access to A Free Sample Copy of Our Latest Report – https://www.globalinsightservices.com/request-sample/GIS10245/
Market Trends and Drivers
The key factor boosting the market growth is an increasing number of blood donations across the globe. There is an increase in the need for donated blood owing to advancements in healthcare systems and the availability of and the need for sophisticated surgical procedures, like cardiovascular & transplant surgery, trauma care, and therapy for cancer and blood diseases. On an average around 235 million major surgeries are being performed across the globe every year, of which 63 million are traumatic surgeries, cancer-related are over 31 million, and 10 million are related to pregnancy complications. Blood transfusion is generally prescribed in complicated childbirth to prepare for childhood congenital maternal blood disorders, acute anemia, and trauma.
Market Segments
By Product & Services
Reagents & Kits
Instruments
By Technology
Nucleic Acid Test
ELISA
Rapid Tests
By End User
Blood Banks
Hospitals
By Regions
North America
Get A Customized Scope to Match Your Need Ask an Expert – https://www.globalinsightservices.com/request-customization/GIS10245/
Key Players
Grifols (Spain)
F. Hoffmann-La Roche Ltd. (Switzerland)
Abbott Laboratories, Inc. (US)
bioMérieux (France)
Bio-Rad Laboratories, Inc. (US)
Becton, Dickinson and Company (US)
Beckman Coulter, Inc. (Danaher) (US)
DiaSorin (Italy)
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1–833–761–1700
0 notes
Text
The method and characteristics of PCR identification kit
PCR Identification Kit Features:
1. One-tube operation, users only need to provide samples.
2. Primers are designed according to the conserved region of soybean heat shock protein gene, which can specifically detect soybean components in the sample, but cannot detect other non-soy components.
3. Fast, the entire detection process (according to one sample) takes only 2.0 hours.
4. Only need common PCR machine and gel electrophoresis machine, no need to configure expensive equipment.
5. The lower limit of detection for soybean components in mixed samples is 0.1%, and the lower detection limit for nucleic acids for soybean components in samples is 1.0ng/μL.
6. This product can only be used for scientific research, enough for 50 times of routine PCR in 40uL system.
How to use PCR identification kit:
1. Dilute the standard curve samples (take 10E2-10E7 copies/μL as an example of six 10-fold dilutions). Since the standard concentration is very high, the following dilution operations must be performed in a separate area, and must not contaminate the sample or other components of the kit).
1.1 Label the 6 centrifuge tubes as 7, 6, 5, 4, 3, and 2.
2.1 Use a cored pipette tip to add 45 μL of fluorescent PCR template dilution solution, *use a cored pipette tip, the same below).
3.1 Add 5 μL of positive control (concentration of 1×10E8 copies/μL, provided by the kit) to the No. 7 tube, shake well for 1 minute, and obtain a standard curve sample of 1×10E7 copies/μL. Set aside on ice.
4. 1Change the pipette tip, add 5 μL of 1×10E7 copies/μL positive control (obtained in the previous step) to tube 6, shake well for 1 minute, and obtain a standard curve sample of 1×10E6 copies/μL. Set aside on ice.
5.1 Change the pipette tip, add 5 μL of 1×10E6 copy/μL positive control (dilution in the previous step) to tube 5, and shake well for 1 minute
clock to obtain a standard curve sample of 1×10E5 copies/μL. Set aside on ice.
6. 1Repeat the above procedure until 6 dilutions of the standard curve samples are obtained. Set aside on ice.
2. Preparation of sample DNA
2.1 Purify the DNA of the sample by the method of your choice. This product is compatible with most nucleic acid purification products on the market.
2.2 If there are N samples, N+2 sample extractions need to be performed, one extra for the sample preparation positive control tube and the other for the sample preparation negative control tube.
2.3.Set up the qPCR reaction (20μL system, in the sample preparation room)
2.4. If doing quantitative analysis and only doing 1 replicate, label N+9 PCR tubes, of which N+2 are for the N+2 samples from the previous step and 1 is for the PCR negative control (use water as template). ), 6 for the standard curve. If qualitative analysis is performed and only 1 repetition is performed, label N+4 PCR tubes, of which N+2 are used for the N+2 samples obtained in the previous step, and 1 is used for PCR negative control (use water as template) , 1 for PCR positive control.
0 notes
Text
Sample Preparation Market 2021 | Business Opportunity, Growth Strategies & Forecast Report By 2027
The Sample Preparation Market Report, in its latest update, highlights the significant impacts and the recent strategical changes under the present socio-economic scenario. The Sample Preparation industry growth avenues are deeply supported by exhaustive research by the top analysts of the industry. The report starts with the executive summary, followed by a value chain and marketing channels study. The report then estimates the CAGR and market revenue of the Global and regional segments.
Base Year: 2020
Estimated Year: 2021
Forecast Till: 2027
The report classifies the market into different segments based on type and product. These segments are studied in detail, incorporating the market estimates and forecasts at regional and country levels. The segment analysis is helpful in understanding the growth areas and potential opportunities of the market.
Get | Download FREE Sample Report of Global Sample Preparation Market @ https://www.decisiondatabases.com/contact/download-sample-8006
A special section is dedicated to the analysis of the impact of the COVID-19 pandemic on the growth of the Sample Preparation market. The impact is closely studied in terms of production, import, export, and supply.
The report covers the complete competitive landscape of the Worldwide Sample Preparation market with company profiles of key players such as:
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
Hamilton Company
Illumina, Inc.
Merck Millipore
Norgen Biotek Corporation
Perkinelmer, Inc.
Qiagen N.V.
Roche Applied Science
Sigma-Aldrich Corporation
Tecan Group Ltd.
Thermo Fisher Scientific, Inc.
Want to add more Company Profiles to the Report? Write your Customized Requirements to us @ https://www.decisiondatabases.com/contact/get-custom-research-8006
Sample Preparation Market Analysis by Product:
Sample Preparation Instruments
Workstations/Systems
Liquid Handling Systems
Liquid Handling Workstations
Pipetting Systems
Reagent Dispensers
Microplate Washers
Other Liquid Handling Systems
Extraction Systems
Other Sample Preparation Instruments
Consumables
Columns
Filters
Tubes
Plates
Other Consumables
Accessories
Sample Preparation Kits
Purification Kits
DNA Purification
RNA Purification
Nucleic Acid Purification
Protein Purification
Isolation Kits
DNA Isolation
RNA Isolation
Nucleic Acid Isolation
Protein Isolation
Extraction Kits
DNA Extraction
RNA Extraction
Nucleic Acid Extraction
Protein Extraction
Other Kits
Sample Preparation Market Analysis by Applications:
Genomics
Proteomics
Epigenomics
Other
Sample Preparation Market Analysis by End User:
Molecular Diagnostics
Applied Testing
Pharmaceutical & Biotechnology
Academic Research Institutes
Sample Preparation Market Analysis by Geography:
North America (USA, Canada, and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South-East Asia, Rest of Asia-Pacific)
Latin America (Brazil, Argentina, Peru, Chile, Rest of Latin America)
The Middle East and Africa (Saudi Arabia, UAE, Israel, South Africa, Rest of the Middle East and Africa)
Key questions answered in the report:
What is the expected growth of the Sample Preparation market between 2022 to 2027?
Which application and type segment holds the maximum share in the Global Sample Preparation market?
Which regional Sample Preparation market shows the highest growth CAGR between 2022 to 2027?
What are the opportunities and challenges currently faced by the Sample Preparation market?
Who are the leading market players and what are their Strengths, Weakness, Opportunities, and Threats (SWOT)?
What business strategies are the competitors considering to stay in the Sample Preparation market?
Purchase the Complete Global Sample Preparation Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-8006
About Us:
DecisionDatabases.com is a global business research report provider, enriching decision-makers, and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research reports, customized research reports, company profiles, and industry databases across multiple domains. Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise, and meaningful data at a lightning speed.
For more details:
DecisionDatabases.com
E-Mail: [email protected]
Phone: +91 90 28 057900
Web: https://www.decisiondatabases.com/
#Sample Preparation Market#Sample Preparation Market Report#Sample Preparation Market Size#Sample Preparation Market Share#Sample Preparation Market Growth
0 notes
Text
Global In Situ Hybridization (ISH) Market Analysis, Share, Growth, Industry Trends, Overview And Forecast To 2025
Global In Situ Hybridization (ISH) Market is expected to reach USD 1.84 billion by 2025. In Situ Hybridization (ISH) is a type of hybridization a method that permits for specific localization of an exact segment of nucleic acid inside a histologic section. That means it involves the use of labeled RNA probes or labeled DNA probes to detect complementary DNA or RNA targets in cytologic preparations or tissue sections. Synthetic oligonucleotides (PNA, LNA), Double-stranded DNA (dsDNA) probes, RNA probes (riboprobes), and Single-stranded DNA (ssDNA) probes are the majorly used ISH probes.
It can be labeled using two major techniques like Non-radioactive labels and radioactive isotopes. A labeled RNA or DNA probe can be used to hybridize to a known target DNA or mRNA sequence within a sample. This labeled RNA or DNA probe can then be detected by using an antibody to detect the label on the probe. The In Situ Hybridization (ISH) industry is estimated to grow at a significant CAGR of 7.3% over the future period as the scope and its applications are rising enormously across the globe. In Situ Hybridization (ISH) Market is segmented based on product type, technology, probe type, application, end use, and region.
Services, instruments, software, and kits & probes are the product types that could be explored in In Situ Hybridization (ISH) in the forecast period. The instruments sector accounted for the largest market share of In Situ Hybridization (ISH) industry and is estimated to continue its dominance in the upcoming years. This may be because of high demand from research laboratories and diagnostic centers. Also, these instruments are easy to handle, cost-efficient, and portable these factors may lead the sector in coming years. However, kits & probes sector is estimated to grow at highest CAGR in the coming years.
Get Free PDF Sample Copy of the Report (Including Full TOC, List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/in-situ-hybridization-ish-market/request-sample
The enhanced technology used in In Situ Hybridization (ISH) is Chromogenic In Situ Hybridization (CISH) and Fluorescent In Situ Hybridization (FISH) that could be explored in the future period. RNA probe and DNA probe are the two main types of probes that could be explored in In Situ Hybridization (ISH) in the foremost period. The DNA probes sector is estimated to account largest revenue shares of In Situ Hybridization (ISH) in the coming years. Whereas, RNA sector is estimated to grow at highest CAGR in the coming years.
The market may be categorized based on applications like infectious diseases, cancer, developmental biology, cytogenetics, and others that could be explored in the future period. Cancer sector accounted for the largest market share of In Situ Hybridization (ISH) and is estimated to grow at highest CAGR in the coming years. The reason could be growing occurrence of cancer and rising research in this sector. However, cytogenetics sector is estimated to grow at fastest pace in the coming years.
End users like academic institutes, research & diagnostic laboratories, contract research organizations (CROs), and others could be explored in In Situ Hybridization (ISH) Market in the forecast period. The research & diagnostic laboratories sector accounted for the largest market share of In Situ Hybridization (ISH) and is estimated to lead the overall market in the coming years. This may be because of growing applications of molecular cytogenetics in diagnostics, rising use of enhanced technology in genomics and molecular cytology, and rising initiative in cell research. However, CROs segment is estimated to grow at fastest pace in the coming years.
Globally, North America accounted for the largest market share of In Situ Hybridization (ISH) and is estimated to lead the overall market in the upcoming years. The reason behind the growth of overall market could be government involvement for development of novel diagnostic tools, availability of research funds, and developed research centers. The United States is a major consumer of In Situ Hybridization (ISH) in this region.
Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The aspects that may be ascribed to the growth comprise, growing awareness regarding advantages of In Situ Hybridization (ISH) technology in diagnostics and government initiative in R&D investments in the field of molecular biology. The developing countries like India and China are the major consumers of In Situ Hybridization (ISH) industry in the region.
The key players of In Situ Hybridization (ISH) Market are Oxford Gene Technology, Thermo Fisher Scientific, Advanced Cell Diagnostics, Inc., Leica BiosystemsNussloch GmbH, NeoGenomics Laboratories, Inc., BIOVIEW, Bio-Rad Laboratories, Inc., Agilent Technologies, PerkinElmer, Inc., and Merck KGaA. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.
Access Full Research Report @
https://www.millioninsights.com/industry-reports/in-situ-hybridization-ish-market
#In Situ Hybridization Market#In Situ Hybridization (ISH) Industry#ISH Market Growth#In Situ Hybridization Market Analysis#In Situ Hybridization (ISH) Market Size#ISH Market Share#In Situ Hybridization Market Report#In Situ Hybridization (ISH) Market Research#ISH Industry Outlook#biotechnology
1 note
·
View note
Text
Immunohistochemistry Market Revenue, Region & Country Share, Trends, Growth Analysis Till 2027
According to the current analysis of Reports and Data, The global Immunohistochemistry market was valued at USD 1,736.4 million in 2018 and is expected to reach USD 3,359.8 million by the year 2026, growing at a CAGR of 8.6%.
Immunohistochemistry (IHC) has crucial applications in the field of tissue distribution of antigens by using monoclonal and polyclonal antibodies. It is used for cancer diagnosis, because it determines the presence of tumor antigens. It is a technique which combines immunological, anatomical, and biochemical processes to identify tissue components by the interaction of target antigens with specific antibodies that are tagged by a label. Immunohistochemistry used by public and private organizations to check localization and distribution of cellular components within the cells.
Immunohistochemistry is being applied in many other areas. Immunohistochemistry is widely used to predict therapeutic response in two important tumors, i.e. carcinoma of breast and prostate. Both these tumors are under the growth regulation of the hormones estrogen and androgen, respectively. The specific receptors for these growth regulating hormones are located on respective tumor cells. Tumors expressing high level of receptor positivity would respond favorably to removal of the endogenous source of such hormones or hormonal therapy is administered to lower their levels – estrogen therapy in prostate cancer and androgen therapy in breast cancer. Immunohistochemistry techniques are also being applied to confirm infectious agent in tissues by use of specific antibodies against microbial DNA or RNA, e.g. in Cytomegalo virus, Hepatitis B virus, Hepatitis C virus, etc. The application is used routinely in validation of disease targets as it allows visualizing expression of the target in the affected tissue during the disease process. Another important advantage of Immunohistochemistry is that it can also be used to detect organisms in cytological preparations such as fluids, sputum samples, and material obtained from fine needle aspiration procedures. This can be very helpful in certain situations such as detection of pneumocystis from the sputum of an immunocompromised patient who needs rapid and precise confirmation of infection in order to begin immediate and appropriate therapy.
Specific diagnosis of muscular dystrophy is important because of the genetic counseling implications of inherited disease and accurate prognostication. In recent years, abnormalities in several muscle proteins have been identified in muscular dystrophies. Such abnormalities involve proteins located in the sarcolemma, extracellular matrix, cytosol, nucleus, and other sites within muscle fibers. Skeletal muscle biopsy can play a main role in differentiating vascular dystrophy from non-dystrophic disorders and Immunohistochemistry can assist in establishing a specific diagnosis of the dystrophies for which specific protein abnormalities are known. In the last few years, immunohistochemical staining for beta amyloid precursor protein has been validated as a method to detect axonal injury within as little as 2–3 h of head injury. Immunohistochemical detection of axonal injury can be useful in establishing timing of a traumatic insult in medico-legal settings.
Rapid growth of healthcare investment in emerging economies and technological development in invitro industry creates the opportunities to manufacturers for Immunohistochemistry kit, equipment and reagents. Growing prevalence of chronic diseases including cancer, cardiovascular diseases, infectious diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases are the key factors for the growth of the market. Significant rise in R&D spending and shift towards comprehensive healthcare solutions are impelling the market growth.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2198
The report provides an in-depth analysis of the key developments and innovations of the market such as research and development advancements, product launches, mergers & acquisitions, joint ventures, partnerships, government deals, and collaborations. The report offers a comprehensive assessment of key players in the market along with their global position, financial standing, business expansion plans, production and manufacturing capacity, and strategic alliances.
Key players in the market include
Abcam plc; Agilent Technologies; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Danaher Corporation; Merck KGaA; PerkinElmer, Inc.; and Thermo Fisher Scientific, Inc.
For a better understanding of the global Immunohistochemistry market dynamics, a regional analysis of the market across key geographical areas is offered in the report. The market is spread across key geographical regions such as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region is analysed on the basis of the market scenario in the major countries of the regions to provide a deeper understanding of the market. It provides insights into production and consumption patterns, supply and demand ratio, export/import, current and emerging trends and demands, market share, market size, revenue contribution, and presence of key players in each region.
Furthermore, the report segments Immunohistochemistry market on the basis of key product types and applications and provides details about the revenue growth, revenue CAGR, and revenue share each segment is expected to register over the forecast period.
Type (Revenue, USD Million; 2017–2027)
Primary Antibodies
Secondary Antibodies
Slide Staining Systems
Tissue Microarrays
Tissue Processing Systems
Slide Scanners
Others
Histological Stains
Blocking Sera and Reagents
Chromogenic Substrates
Fixation Reagents
Stabilizers
Organic Solvents
Proteolytic Enzymes
Diluents
Application (Revenue, USD Million; 2017–2027)
Cancer
Infectious Diseases
Cardiovascular Diseases
Autoimmune Diseases
Diabetes Mellitus
Nephrological Diseases
End Use (Revenue, USD Million; 2017–2027)
Hospitals and Diagnostic Laboratories
Clinics
Research Institutes
Others
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2198
In-depth regional analysis includes:
· North America (U.S., Canada, Mexico)
· Europe (Italy, U.K., Germany, France, Rest of EU)
· Asia Pacific (India, China, Japan, South Korea, Australia, Rest of APAC)
· Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)
· Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
To know more about the report @ https://www.reportsanddata.com/report-detail/immunohistochemistry-market
Benefits of the Global Immunohistochemistry Report:
• Comprehensive analysis of the opportunities and risks of the Immunohistochemistry market
• Detailed study of the latest product and technological developments and innovations of the Immunohistochemistry market
• Business strategies and plans are analysed for understanding the Immunohistochemistry market scenario
• Revenue forecast of Immunohistochemistry market for the forecast period 2020-2027
• Comprehensive analysis of the drivers, constraints, limitations, challenges, and opportunities
• Latest and emerging market trends analysis and their impact on product and application demand
• Study of recent M&A, joint ventures, collaborations, partnerships, product launches and brand promotions among others
• Extensive SWOT analysis and Porter’s Five Forces analysis along with investment return analysis and feasibility
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2198
Thank you for reading our report. Please get in touch with us to know more about the report and customization of the report. Our team will ensure the report is tailored to meet your requirements.
Browse More Reports :
Assisted Reproductive Technology (ART) Market@https://www.reportsanddata.com/report-detail/assisted-reproductive-technology-art-market
Nucleic Acid Testing Market@https://www.reportsanddata.com/report-detail/nucleic-acid-testing-market
0 notes
Text
DNA/RNA Sample Preparation Market Future Trends to Look Out | Bis Research
DNA-RNA sample preparation refers to the series of laboratory procedures used to extract, purify, and prepare both DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) from biological samples for further analysis.
The global DNA/RNA Sample Preparation Market is projected to reach $5,615.9 million by 2033 from $2,922.8 million in 2023, growing at a CAGR of 6.75% during the forecast period 2023-2033.
DNA/RNA Sample Preparation Market Overview
DNA-RNA sample preparation is a fundamental process in molecular biology, involving the extraction, purification, and preparation of both DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) from biological samples for subsequent analysis.
Key Steps in DNA/RNA Sample Preparation Market
Sample Collection
Cell Lysis
Nucleic Acid Isolation
Purification
Quantification and Quality Assessment
Importance of DNA RNA Sample Preparation
Genomic Sequencing: Accurate sequencing requires pure and intact nucleic acids.
Gene Expression Analysis: Reliable quantification of gene expression levels depends on high-quality RNA.
Molecular Diagnostics: Diagnostic tests for genetic diseases, infections, and cancers require precise nucleic acid samples.
Research in Molecular Biology and Genetics: Fundamental research studies depend on pure DNA and RNA to investigate cellular processes and genetic functions.
Grab a look at the free sample page for more understanding click here !
Visit our Precision Medicine Vertical Page Click Here !
Market Segmentation
Product Type
End Users
Applications
Geography
Various different applications involved are as follows
Genomic Sequencing
Gene Expression Analysis
Molecular Diagnostics
Forensic Analysis
Stem Cell Research
And many others
Recent Developments in the DNA/RNA Sample Preparation Market
Qiagen N.V. introduced two groundbreaking additions to its sample technologies portfolio, i.e., the TissueLyser III that facilitates high-throughput disruption of diverse biological samples and the RNeasy PowerMax Soil Pro Kit that isolates high-purity RNA from challenging soil samples using advanced Inhibitor Removal Technology.
PerkinElmer introduced the CHEF Magnetic Bead Cleanup System, providing automated nucleic acid purification through advanced magnetic bead technology. This novel system would help automate the nucleic acid purification process efficiently.
Conclusion
In conclusion DNA-RNA sample preparation is a vital and multifaceted process in molecular biology and biotechnology, laying the groundwork for a multitude of scientific, diagnostic, and industrial applications.
The significance of this process cannot be overstated, as it forms the backbone of experimental integrity and data reproducibility. As technology evolves and new applications emerge, the methodologies for DNA-RNA sample preparation
0 notes
Text
Blood Transfusion Diagnostics Market Research Report - Global Forecast Till 2027
Global Blood Transfusion Diagnostics Market Information, by product (Red Blood Cells, Platelets, Plasma, Albumin, Immunoglobulin Preparations, others) by Technology (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test, others) by end user (Hospitals, Clinics, Blood banks, Laboratories) - Forecast till 2027
Ortho Clinical Diagnostics (U.S), Immucor (U.S), Beckman Coulter (U.S), Grifols (Spain), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), bioMérieux (France), Bio-Rad Laboratories, Inc. (U.S.), Siemens (Germany), Becton, Dickinson and Company (U.S.), Novartis AG (Switzerland), Beckman Coulter, Inc. (U.S.), Diagast (France), Abbott Diagnostics (U.S), BAG healthcare (Germany), DiaSorin (Italy), Fujirebio (Belgium), Grifols (Spain), Quidel (U.S), Hologic/Gen-Probe (U.S), Biokit (Spain).are some of the prominent players at the forefront of competition in the global Blood Transfusion Diagnostics market and top seven players are profiled in MRFR Analysis.
Global Blood Transfusion Diagnostics Market - Overview
Blood transfusion is an essential part of providing healthcare services to the patients. Blood and blood products like RBC’s, WBC’s, platelets and others are transfused from one person to another. This requires screening tests which are vital before conducting blood transfusion. Strict regulation governing the use and transfer of blood, increasing awareness regarding blood transfusion and automation of blood banks drive the growth of this market. Furthermore, increasing demand for diagnostic and treatment devices in developed and developing countries further influence the growth of the market. However, the growth of the market is restrained by various factors such as risk involved in transmission of infectious disease from one person to another without carrying out screening procedure.
Global Blood Transfusion Diagnostics Market - Competitive Analysis
There is a significant increase in the number of the company offering blood transfusion diagnostics. Some major companies are trying to focus on new and advanced tests & products to gain the market. Whereas, some are has used the technique of acquisition and collaboration to gain the market.
Hoffmann-La Roche AG:
August, 2015: F. Hoffmann-La Roche AG acquired GeneWEAVE to strengthen offerings in microbiology diagnostics. Roche will pay GeneWEAVE shareholders USD 190 million upfront and up to USD 235 million in contingent product related milestones
February 2015 : F. Hoffmann-La Roche AG announced the collaboration with BioMed X for the development of Nanomaterial-Based Biosensors for Near-Patient Testing
September 2014: F. Hoffmann-La Roche AG launched Elecsys anti-Müllerian Hormone (AMH) fertility test for assessment of ovarian reserve for pregnancy
Abbott:
June, 2017: Alere shareholders approve amended merger with Abbott. This merger will further strengthen the global presence of the company.
August, 2016: Abbott announced the introduction of its new “Alinity”, a family of next generation systems across immunoassay, clinical chemistry, point of care, haematology, blood and plasma screening and molecular diagnostics.
April, 2016: The company received FDA approval for its companion diagnostics “Vysis CLL FISH probe kit” in Leukemia. The kit is used to detect the 17p deletion in chronic lymphocytic leukemia patients, the target population of a new drug from AbbVie.
April, 2016: Abbott received FDA approval for its companion diagnostics “Vysis CLL FISH probe kit” in Leukemia. The kit is used to detect the 17p deletion in chronic lymphocytic leukemia patients, the target population of a new drug from AbbVie.
Bio-Rad Laboratories, Inc.:
July 2017: Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products launched Amplichek I quality control for the testing of infectious diseases.
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1126
Global Blood Transfusion Diagnostics Market - Regional Analysis
Globally, America’s account for the largest market share in blood transfusion diagnostics market consists of two regions namely North America and South America. Increasing in number of blood banks, adoption of automation in blood banks, awareness programs in school & medical institutes and demand of safe and reliable technology for blood transfusion drive this market in North America. Increasing adoption of Nucleic Acid Amplification for diagnosis of blood and blood products also contribute to the growth of this market in North America. United States is the biggest market place worldwide contributing 46% of total blood transfusion diagnostics market. Ortho-Clinical Diagnostic is the largest transfusion diagnostic equipment and solution provider with estimated market share of 7 to 8%. Medical institutes conduct lecture and conference on safe blood transfusion for medical students and also for patients. Europe blood transfusion diagnostics market has observed stable growth owing to increasing demand for advanced diagnostic products. Asia-Pacific is fastest growing market region for this market due to presence of huge patient pool, and huge opportunity for the market growth. The Middle East and Africa holds the least share in the market due to lack of awareness among the people and limited development of medical sector.
Table Of Contents
1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Threats
4.5 Macroeconomic Indicators
5. Market Factor Analysis
5.1 Value Chain Analysis
5.2 Porters Five Forces
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis
5.6 Merger And Acquisition Landscape
5.7 Up-Coming Trends In Blood Transfusion Diagnostics Market
5.7.1 Market Trends
5.7.2 Technological Trends
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/blood-transfusion-diagnostics-market-1126
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Related Report:
Global Acute Pancreatitis Market Research Report—Forecast till 2025
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
DNA RNA Extraction Kit Market Size, Type, segmentation, growth and forecast 2023-2030
DNA RNA Extraction Kit Market
The DNA RNA Extraction Kit Market is expected to grow from USD 1.30 Billion in 2022 to USD 2.20 Billion by 2030, at a CAGR of 7.26% during the forecast period.
Get the Sample Report: https://www.reportprime.com/enquiry/sample-report/11096
DNA RNA Extraction Kit Market Size
The DNA RNA Extraction Kit market research report analyzes the global market segment based on product type (DNA Extraction Kit, RNA Extraction Kit), end-use application (Hospital, Laboratory, Other), and geography (North America, Asia Pacific, Middle East, Africa, Australia and Europe), with the leading market players including Qiagen, Thermo Fisher Scientific, Merck KGaA, Roche, Cytiva, Agilent, Danaher, Promega, Bio-Rad, Bioneer, and Akonni Biosystems. The report dives deep into the dynamics of the market and the regulatory and legal factors, such as the increasing incidence of genetic disorders and the growing demand for personalized medicine and research on gene-based therapies. The market growth can be attributed to technological advancements, increasing research and development activities, and the need for quick, accurate, and efficient extraction of nucleic acids. The report anticipates continued market growth in the future.
DNA RNA Extraction Kit Market Key Player
Qiagen
Thermo Fisher Scientific
Merck KGaA
Roche
Cytiva
Buy Now & Get Exclusive Discount on this https://www.reportprime.com/enquiry/request-discount/11096
DNA RNA Extraction Kit Market Segment Analysis
The DNA RNA Extraction Kit market targets customers in research and biotechnology laboratories, pharmaceutical companies, academic institutions, and diagnostic centers. The increasing demand for effective and efficient research tools for genetic analysis and clinical diagnostics is driving the revenue growth of the DNA RNA Extraction Kit market. The rising incidence of genetic diseases, cancer, and infectious diseases have led to increased demand for DNA RNA Extraction Kits as a primary step in genetic analysis and diagnosis.
One of the latest trends in the DNA RNA Extraction Kit market is the development of fully automated and high-throughput extraction systems, which enable faster and more efficient extraction of DNA and RNA from different sample types. Moreover, the growing popularity of personalized medicine and genomic-based research is expected to fuel the demand for DNA RNA Extraction Kits in the coming years.
The major challenge faced by the DNA RNA Extraction Kit market is the high cost of these kits, which may limit their accessibility, particularly in developing countries. Additionally, quality control issues in sample preparation and the lack of standardization in DNA RNA extraction protocols may also restrain the growth of the market.
The main findings of the DNA RNA Extraction Kit market report suggest that North America holds the largest share due to the presence of major market players in the region, while the Asia-Pacific region is expected to witness the fastest growth due to the rising demand for molecular diagnostics in the region.
The report recommends market players to focus on product innovation, developing cost-effective and easy-to-use DNA RNA Extraction Kits, and expanding their global reach through strategic partnerships and collaborations. Additionally, the report suggests that regulatory bodies should establish standardized protocols for DNA RNA extraction to ensure consistency and reliability in research and clinical diagnostics.
This report covers impact on COVID-19 and Russia-Ukraine wars in detail.
Purchase This Report: https://www.reportprime.com/checkout?id=11096&price=3590
Market Segmentation (by Application):
Hospital
Laboratory
Other
Information is sourced from www.reportprime.com
0 notes
Text
In Situ Hybridization (ISH) Market Research: Growth Opportunities by Regions, Types, Applications & Forecast to 2025
7th May 2021 – Global In Situ Hybridization (ISH) Market is expected to reach USD 1.84 billion by 2025. In Situ Hybridization (ISH) is a type of hybridization a method that permits for specific localization of an exact segment of nucleic acid inside a histologic section. That means it involves the use of labeled RNA probes or labeled DNA probes to detect complementary DNA or RNA targets in cytologic preparations or tissue sections. Synthetic oligonucleotides (PNA, LNA), Double-stranded DNA (dsDNA) probes, RNA probes (riboprobes), and Single-stranded DNA (ssDNA) probes are the majorly used ISH probes.
It can be labeled using two major techniques like Non-radioactive labels and radioactive isotopes. A labeled RNA or DNA probe can be used to hybridize to a known target DNA or mRNA sequence within a sample. This labeled RNA or DNA probe can then be detected by using an antibody to detect the label on the probe. The In Situ Hybridization (ISH) industry is estimated to grow at a significant CAGR of 7.3% over the future period as the scope and its applications are rising enormously across the globe. In Situ Hybridization (ISH) Market is segmented based on product type, technology, probe type, application, end use, and region. Services, instruments, software, and kits & probes are the product types that could be explored in In Situ Hybridization (ISH) in the forecast period. The instruments sector accounted for the largest market share of In Situ Hybridization (ISH) industry and is estimated to continue its dominance in the upcoming years. This may be because of high demand from research laboratories and diagnostic centers. Also, these instruments are easy to handle, cost-efficient, and portable these factors may lead the sector in coming years. However, kits & probes sector is estimated to grow at highest CAGR in the coming years.
Access In Situ Hybridization (ISH) Market Report with TOC @ https://www.millioninsights.com/industry-reports/in-situ-hybridization-ish-market
The enhanced technology used in In Situ Hybridization (ISH) is Chromogenic In Situ Hybridization (CISH) and Fluorescent In Situ Hybridization (FISH) that could be explored in the future period. RNA probe and DNA probe are the two main types of probes that could be explored in In Situ Hybridization (ISH) in the foremost period. The DNA probes sector is estimated to account largest revenue shares of In Situ Hybridization (ISH) in the coming years. Whereas, RNA sector is estimated to grow at highest CAGR in the coming years. The market may be categorized based on applications like infectious diseases, cancer, developmental biology, cytogenetics, and others that could be explored in the future period. Cancer sector accounted for the largest market share of In Situ Hybridization (ISH) and is estimated to grow at highest CAGR in the coming years. The reason could be growing occurrence of cancer and rising research in this sector. However, cytogenetics sector is estimated to grow at fastest pace in the coming years.
End users like academic institutes, research & diagnostic laboratories, contract research organizations (CROs), and others could be explored in In Situ Hybridization (ISH) Market in the forecast period. The research & diagnostic laboratories sector accounted for the largest market share of In Situ Hybridization (ISH) and is estimated to lead the overall market in the coming years. This may be because of growing applications of molecular cytogenetics in diagnostics, rising use of enhanced technology in genomics and molecular cytology, and rising initiative in cell research. However, CROs segment is estimated to grow at fastest pace in the coming years.
Globally, North America accounted for the largest market share of In Situ Hybridization (ISH) and is estimated to lead the overall market in the upcoming years. The reason behind the growth of overall market could be government involvement for development of novel diagnostic tools, availability of research funds, and developed research centers. The United States is a major consumer of In Situ Hybridization (ISH) in this region. Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The aspects that may be ascribed to the growth comprise, growing awareness regarding advantages of In Situ Hybridization (ISH) technology in diagnostics and government initiative in R&D investments in the field of molecular biology. The developing countries like India and China are the major consumers of In Situ Hybridization (ISH) industry in the region.
The key players of In Situ Hybridization (ISH) Market are Oxford Gene Technology, Thermo Fisher Scientific, Advanced Cell Diagnostics, Inc., Leica BiosystemsNussloch GmbH, NeoGenomics Laboratories, Inc., BIOVIEW, Bio-Rad Laboratories, Inc., Agilent Technologies, PerkinElmer, Inc., and Merck KGaA. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.
Request a Sample Copy of In Situ Hybridization (ISH) Market Report @ https://www.millioninsights.com/industry-reports/in-situ-hybridization-ish-market/request-sample
0 notes
Text
In Situ Hybridization (ISH) Market Product Driving Factors, Capacity and Growth Rate Analysis to 2025
7th May 2021 – Global In Situ Hybridization (ISH) Market is expected to reach USD 1.84 billion by 2025. In Situ Hybridization (ISH) is a type of hybridization a method that permits for specific localization of an exact segment of nucleic acid inside a histologic section. That means it involves the use of labeled RNA probes or labeled DNA probes to detect complementary DNA or RNA targets in cytologic preparations or tissue sections. Synthetic oligonucleotides (PNA, LNA), Double-stranded DNA (dsDNA) probes, RNA probes (riboprobes), and Single-stranded DNA (ssDNA) probes are the majorly used ISH probes.
It can be labeled using two major techniques like Non-radioactive labels and radioactive isotopes. A labeled RNA or DNA probe can be used to hybridize to a known target DNA or mRNA sequence within a sample. This labeled RNA or DNA probe can then be detected by using an antibody to detect the label on the probe. The In Situ Hybridization (ISH) industry is estimated to grow at a significant CAGR of 7.3% over the future period as the scope and its applications are rising enormously across the globe. In Situ Hybridization (ISH) Market is segmented based on product type, technology, probe type, application, end use, and region. Services, instruments, software, and kits & probes are the product types that could be explored in In Situ Hybridization (ISH) in the forecast period. The instruments sector accounted for the largest market share of In Situ Hybridization (ISH) industry and is estimated to continue its dominance in the upcoming years. This may be because of high demand from research laboratories and diagnostic centers. Also, these instruments are easy to handle, cost-efficient, and portable these factors may lead the sector in coming years. However, kits & probes sector is estimated to grow at highest CAGR in the coming years.
Access In Situ Hybridization (ISH) Market Report with TOC @ https://www.millioninsights.com/industry-reports/in-situ-hybridization-ish-market
The enhanced technology used in In Situ Hybridization (ISH) is Chromogenic In Situ Hybridization (CISH) and Fluorescent In Situ Hybridization (FISH) that could be explored in the future period. RNA probe and DNA probe are the two main types of probes that could be explored in In Situ Hybridization (ISH) in the foremost period. The DNA probes sector is estimated to account largest revenue shares of In Situ Hybridization (ISH) in the coming years. Whereas, RNA sector is estimated to grow at highest CAGR in the coming years. The market may be categorized based on applications like infectious diseases, cancer, developmental biology, cytogenetics, and others that could be explored in the future period. Cancer sector accounted for the largest market share of In Situ Hybridization (ISH) and is estimated to grow at highest CAGR in the coming years. The reason could be growing occurrence of cancer and rising research in this sector. However, cytogenetics sector is estimated to grow at fastest pace in the coming years.
End users like academic institutes, research & diagnostic laboratories, contract research organizations (CROs), and others could be explored in In Situ Hybridization (ISH) Market in the forecast period. The research & diagnostic laboratories sector accounted for the largest market share of In Situ Hybridization (ISH) and is estimated to lead the overall market in the coming years. This may be because of growing applications of molecular cytogenetics in diagnostics, rising use of enhanced technology in genomics and molecular cytology, and rising initiative in cell research. However, CROs segment is estimated to grow at fastest pace in the coming years.
Globally, North America accounted for the largest market share of In Situ Hybridization (ISH) and is estimated to lead the overall market in the upcoming years. The reason behind the growth of overall market could be government involvement for development of novel diagnostic tools, availability of research funds, and developed research centers. The United States is a major consumer of In Situ Hybridization (ISH) in this region. Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The aspects that may be ascribed to the growth comprise, growing awareness regarding advantages of In Situ Hybridization (ISH) technology in diagnostics and government initiative in R&D investments in the field of molecular biology. The developing countries like India and China are the major consumers of In Situ Hybridization (ISH) industry in the region.
The key players of In Situ Hybridization (ISH) Market are Oxford Gene Technology, Thermo Fisher Scientific, Advanced Cell Diagnostics, Inc., Leica BiosystemsNussloch GmbH, NeoGenomics Laboratories, Inc., BIOVIEW, Bio-Rad Laboratories, Inc., Agilent Technologies, PerkinElmer, Inc., and Merck KGaA. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.
Request a Sample Copy of In Situ Hybridization (ISH) Market Report @ https://www.millioninsights.com/industry-reports/in-situ-hybridization-ish-market/request-sample
0 notes
Text
Human Identification Market Opportunity Assessment, Global Analysis and Forecast Report To 2029
Forensic identification technologies are used to identify specific objects from the various types of traced evidences at the place of accident and disaster. Human identification techniques are mainly used in forensics for the identification of criminals. Fingerprints are used as a source of identification of human beings
Human identification is a part of forensic sciences, where samples of blood, skin, and DNA are used to identify specific objects. In human identification, finger prints are most often used to recognize and detect human beings. Based on the process of analyzing and recognizing the ridges present on the fingers, technology is one of the pillars of human identification. Technological advances are being increasingly used in the field of human identification to improve the accuracy and reduce the time taken for the process. For instance: rapid DNA analysis has become a crucial aspect of improving the human identification process, that offers advantages such as reduced cost and time required, and convenience.
There has been a push in recent times globally to increase the awareness quotient about the processes and technologies used in DNA analysis and human identification. With initiatives being undertaken by governmental and regulatory organizations in the industry, this market has seen significant growth in recent years, and research and development has placed minimizing time at the focus of it.
While the human identification market is set to expand during the forecast period, price erosion in genomics instruments and genomics continues, which pose a challenge to the manufacturers, is expected to act as a restraint holding back the growth of the market to its fullest potential.
For more insights into the Market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5078
An Overview of the Human Identification Market
The global human identification market value is expected to be US$ 785 Mn by 2019 end, as indicated by a new report of Future Market Insights (FMI). The market is further projected for a strong 6% CAGR during the forecast period, 2019 – 2029. A consistent rise in the number of natural disasters and fatal road accidents strongly necessitate the demand for more effective forensic DNA technologies for human identification. This would remain an important factor responsible for incremental growth of human identification market.
This report on the human identification market offers significant insights about the underlying trends, prospective opportunities, drivers and the restraints of the landscape. This gives players the opportunity to amend and formulate business strategies for the future. This report also has information about eh various stakeholders in the market, including manufacturers, distributors, and suppliers, who can all benefit from the insights in it.
Structure of the Report
The report starts with an executive summary which is a glimpse into the information contained in this study of the human identification market. This is followed by a detailed qualitative analysis based on segments such as product, modality, end user and region in the global market. The report also consists of an overview of the global market with specific analysis of the various geographical regions, namely North America, Latin America, Europe, Japan, APEJ and MEA, and the estimated future trajectories of the same. The study of the human identification market by FMI also has an entire section devoted to the key players in the market as well an as examination of their growth strategies, giving them the competitive advantage in the landscape and this information can be particularly useful for new entrants into the human identification market
Get Access to Research Methodology Prepared by Experts>>> https://www.futuremarketinsights.com/ask-question/rep-gb-5078
Key Segment
Product
Instruments
Software & Data Management
Assay Kits & Cartridges
Other Consumables
DNA Collection Systems
Electrophoresis Systems
Thermal Cyclers
Rapid DNA Analysis Systems
NGS Platforms
Microarray Scanners
Others
Analytical Software
Data Interpretation
Data Storage
DNA Sample Preparation & Extraction Kits
DNA Amplification Kits
DNA Quantification Kits
Rapid DNA Analysis Cartridges
Technology
Polymerase chain reaction (PCR)
Short Tandem Repeats (STR)
Microarray Technology
Capillary Electrophoresis
Next Generation Sequencing (NGS)
Nucleic Acid Extraction and Purification
Rapid DNA Analysis
Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/5078
Application
Molecular Forensic Analysis
DNA Database Updating
Paternity & Kinship Testing
Crime and Sexual Assault Investigation
Missing Person Investigation
Disaster Victim Identification
Anthropology Studies
Cell Line Identification
Population-based Studies
Genetic-based Studies
End User
Forensic laboratories
Law Enforcement Agencies
Academic and Research Labs
Pharmaceutical and Biotech Companies
Contract Research Organizations
Others
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle-East & Africa
#Human Identification Market#Human Identification Market CAGR#Human Identification Market Key Players
0 notes
Last Seen Blogs
annewrighthglc
I like being looked at and you like to look
girlonlne
GirlOn Line
arkocompanies
Arko Companies
shopping-center-njhazlet
Shорріng In Hazlet NJ
pressstartmark
Press Start Mark Gaming Youtube Page SUB